相关实验视频

Updated: Sep 14, 2025

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

检查点免疫治疗的幽默决定因素

Yile Dai¹, Lilach Aizenbud², Kai Qin³

¹Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA.

|July 23, 2025

概括

针对细胞外蛋白的自身抗体显著影响癌症免疫治疗反应. 这些自身抗体可以中和关键蛋白质,提供新的治疗点,以提高检查点免疫疗法的有效性.

科学领域:

免疫学
癌症学
蛋白质组学

背景情况:

细胞免疫在癌症检查点免疫疗法 (CPI) 中的作用已确立,但抗体介导的幽默免疫的影响仍然不太清楚.
自体抗体可以影响治疗结果,因此需要对其在CPI中的作用进行更深入的研究.

研究的目的:

在接受CPI的癌症患者中,将自身抗体反应组与外蛋白组进行映射.
确定与CPI反应和免疫相关不良事件有关的特定自身抗体.
探索自身抗体的功能影响及其治疗潜力.

主要方法:

使用快速的细胞外抗原分析,对6,172种细胞外和分泌的蛋白质进行自身抗体分析.
在374名用CPI治疗的癌症患者中,与131名健康对照者的自身抗体概况进行比较.
进行功能评估和临床前小鼠模型以评估自身抗体效应.

主要成果:

与健康个体相比,接受CPI治疗的患者表现出明显且较高的自身抗体概况.
特定的自身抗体,包括向免疫调节蛋白和瘤表面蛋白,与CPI反应的改变有关.
在临床前模型中,针对I型干扰素 (IFN- I) 和TL1A的自身抗体中和了标蛋白活性,并增强了CPI疗效.

结论:

对外蛋白体的自身抗体是检查点免疫疗法的关键调节剂.
确定了特定的自身抗体及其中和的标,作为增强癌症免疫疗法的潜在治疗标.
这些发现突出了通过调节体内免疫来改善CPI结果的可行途径.

更多相关视频

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on: May 2, 2025

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Humoral Immune Responses

Humoral Immune Responses

B Cell Activation and Differentiation

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...

Cell-mediated Immune Responses

Cell-mediated Immune Responses

T Cell Activation and Clonal Selection

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...